C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research

TUCSON, Ariz., March 28, 2024 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for potential therapies for Duchenne muscular dystrophy (DMD). This pioneering Drug Development Tool is set to positively impact the medical research community by significantly optimizing clinical trial design.Continue reading

AZBio Members – Apply before April 19th for MTC Flex Pass Savings

The Medtech Conference, October 15-17, 2024 in Toronto, Canada features the new Medtech campus, thousands of medtech professionals and innovative companies, a curated cross-cutting education program, invaluable access to key decision makers, next-level technology and efficient networking. Join us to gain insights, connections, and advancements to propel your company forward in the dynamic medical technology landscape.Continue reading

Breakthrough Results of NIH-Sponsored Study of Syn-One Test® as a Skin-Based Diagnostic Tool for Parkinson’s Disease and Related Disorders Published in the Journal of the American Medical Association

  • Study demonstrates alpha-synuclein biomarker can be detected in 93-100% of patients with clinically defined pathologies using simple skin biopsy procedure
  • Syn-One Test addresses key unmet needs by supporting accurate diagnoses for patients and serving as a reliable biomarker for clinical trials

Continue reading